AcelRx appoints general counsel
Pharmaceutical company AcelRx Pharmaceuticals announced the appointment of John Saia as general counsel, effective as of April 16.
Related articles
-
OpinionThe AI audit burden: Why ‘Explainable AI’ is the key
AI decisions are only defensible when the reasoning behind them is visible, traceable, and auditable. Explainable AI delivers that visibility, turning black-box outputs into documented logic that compliance officers can stand behind when regulators, auditors, or stakeholders demand answers.
-
ArticleFrench court calls out alleged deceptive net zero claims by TotalEnergies
Regulators in Europe are focused on punishing energy firms that make deceptive claims on net zero targets, as TotalEnergies recently discovered.
-
ResourceWhite paper: How Typological Regulations are Redefining Corporate Compliance
This report quantifies, analyzes, and visualizes the impact of typological regulations on compliance so that teams can more efficiently and effectively protect against non-obvious sources of regulatory risk.